eBook, ePUB

Advances in CRISPR/Cas and Related Technologies (eBook, ePUB)

Beschreibung

Advances in CRISPR/Cas and related technologies, Volume 179, the latest release in this ongoing series, deals with a wide variety of research topics related to recent advancement in the genome editing techniques. Associated chapters in this new release include Challenges for Therapeutic application of CRISPR Cas techniques, Mitochondrial DNA modification by CRISPR Cas System: Challenges and future direction, Trends in CRISPR Cas technology application in cancer, Modified CRISPR-Cas for next generation application, Application of CRISPR Cas in Synthetic Biology: Challenges and Scopes, History of CRISPR Cas system from bacterial Adaptive Immune System to research application, and more. - Covers the Cas9 protein modification for reduced off-target effect - Includes discussions on Cas9 utilization for Metabolic Engineering - Provides information on the use of Cas9 for targeted delivery in therapeutic application

Technische Details

• Geräte: eReader
• ohne Kopierschutz
• Größe: 24.28MB

Barrierefreiheit

• Text-to-Speech
• E-Mail des Verlags für Barrierefreiheitsfragen: [e-mail]
• Link zum Nachweis der Barrierefreiheitskompatibilität: https://www.elsevier.com/about/accessibility
• Link zur Verlagsseite mit Barrierefreiheitsinformationen: https://www.elsevier.com/about/accessibility
• Weiterführende Informationen zur Barrierefreiheit: https://www.elsevier.com/about/accessibility
• Datum der letzten Bewertung der Barrierefreiheit: 20250611
• Funktion von Links und Steuerelementen klar erkennbar
• Alle Texte können hinsichtlich Größe, Schriftart und Farbe angepasst werden
• Grundlegende Landmark-Navigation für einfache Orientierung
• Inhalte verständlich ohne Farbwahrnehmung
• Sprache des Textes für Text-to-Speech optimiert
• Text und Medien in logischer Lesereihenfolge angeordnet
• Navigierbares Inhaltsverzeichnis für direkten Zugriff auf Text und Medien
• Keine Einschränkung der Vorlesefunktionen, außer bei spezifischen Ausnahmen

Autor

Dr. Dipanjan Ghosh has almost 19 years of research experience in the field of Molecular Biology, Cell Biology, Biochemistry, Immunology and genome editing. Presently Dr. Ghosh is working as Assistant Professor in the Department of Natural Products at National Institute of Pharmaceutical Education and Research (NIPER)-Kolkata. After getting MSc. in Biochemistry from University of Calcutta, Dr. Ghosh went to Indian Institute of Technology (IIT) Kharagpur where he did his MTech in Biotechnology and Bioprocess Engineering and then PhD in the field of Immunology, Cancer Biology Biochemistry. In his first postdoc at University of Texas Health Science Centre at Houston he worked in the field of catalytic enzyme. He then moved to UT MD Anderson Cancer Centre, Houston TX where he gained enough experience in field of genome editing using ZFN and CRISPR Cas systems. Dr. Ghosh received DST FAST TRACK YOUNG SCIENTIST GRANT from Department of Science and Technology, India. Presently he has init

iated Synthetic Biology through metabolic bioengineering at his lab and acting as leading investigator of two major funded projects (one from DBT and another one from WBDBT) in the field of CRISPR Cas mediated genome editing.
Dr. Ghosh has enough experience, skill, knowledge and publication in the field of genome editing.

Produktdetails

• Verlag: Elsevier Science & Techn.
• Seitenzahl: 284
• Erscheinungstermin: 5. März 2021
• Englisch
• ISBN-13: 9780128215913
• Artikelnr.: 61681965